Estimating The Impact Associated To The Use Omalizumab In The Treatment of Severe Persistent Allergic Asthma In Portugal – Evaluating Outcomes And Treatment Costs Using Real World Data From Portuguese Patients
Abstract
Authors
I Moital J Carrasco I Cardoso D Mesquita J Felix B Vandewalle